Current state, control, impact and management of rheumatoid arthritis according to patient: AR 2020 national survey
Por:
Alcaide L, Torralba AI, Eusamio Serre J, García Cotarelo C, Loza E and Sivera F
Publicada:
1 mar 2022
Ahead of Print:
1 mar 2022
Categoría:
Rheumatology
Resumen:
Objectives: To analyse current status, control and impact of RA on patients' lives as well as the management of RA symptoms. Methods: A structured anonymous online questionnaire was designed and sent to patients with RA, aged 18 years or above living in Spain. Participants were invited though different strategies: 1) ConArtritis and related patients associations; 2) Patients participating in the platform www.in-pacient.es; 3) Links from ConArtritis website and open social networks. Sociodemographic and clinical variables, as well as others related to the objectives were collected. A descriptive analysis was performed. Results: We analysed 882 RA patients, 89% women, with a median age of 52 years, 31.9% disease duration < 5 years. They reported a mean pain and patient global disease score (0-10) of 5.1 and 4.9 respectively. The rate of patients with many difficulties or inability to perform daily tasks varied from 6.4% to 49.2%. Based on the activity index 56.8% of patients reported high activity. We found a great or severe impact on the emotional well-being in 31.5% of patients, and of 29.2% in the workplace or academic setting. A total of 87.9% are taking some medication for RA, and 17.3% are little/not satisfied with them. In addition, 67.1% take conventional synthetic disease modifying drugs (DMARDs), and 45.9% biological therapies including biosimilars and small molecules. Conclusions: The current impact of RA on patients' daily lives remains very high. A significant number of patients are not taking DMARDs (conventional synthetic and/or biologics) despite high activity.(c) 2020 Elsevier Espan tilde a, S.L.U. and Sociedad Espan tilde ola de Reumatologi acute accent a y Colegio Mexicano de Reumatologi acute accent a. All rights reserved.
Filiaciones:
Alcaide L:
Coordinadora Nacional de Artritis, Madrid, España
Torralba AI:
Coordinadora Nacional de Artritis, Madrid, España
Eusamio Serre J:
Ekineo Business Intelligence, Barcelona, España
García Cotarelo C:
Ekineo Business Intelligence, Barcelona, España
Loza E:
Instituto de Salud Musculoesquelética, Madrid, España
:
Servicio de Reumatología, Hospital General de Elda, Alicante, España. Electronic address:
FULL TEXT
 |
Published Version |
This policy does not allow for Open Access for this version. |
| No Accesible |
|